Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Nov 28, 2016 $3.15 $3.24 $2.92 $3.09 310 834
Nov 25, 2016 $3.32 $3.35 $2.87 $3.18 287 500
Nov 23, 2016 $2.89 $3.30 $2.81 $3.29 828 728
Nov 22, 2016 $2.73 $3.18 $2.71 $2.94 1 467 523
Nov 21, 2016 $2.74 $2.77 $2.53 $2.66 98 471
Nov 18, 2016 $2.72 $2.86 $2.61 $2.75 87 266
Nov 17, 2016 $2.83 $2.87 $2.52 $2.71 109 854
Nov 16, 2016 $2.98 $3.10 $2.79 $2.85 194 210
Nov 15, 2016 $2.77 $3.20 $2.74 $3.00 343 324
Nov 14, 2016 $2.95 $3.05 $2.63 $2.74 191 975
Nov 11, 2016 $2.15 $3.15 $2.13 $2.93 404 543
Nov 10, 2016 $2.22 $2.23 $2.10 $2.15 166 270
Nov 09, 2016 $2.22 $2.33 $2.17 $2.20 114 770
Nov 08, 2016 $2.00 $2.32 $1.99 $2.16 110 500
Nov 07, 2016 $1.96 $2.05 $1.96 $1.97 38 000
Nov 04, 2016 $1.82 $1.99 $1.81 $1.95 56 100
Nov 03, 2016 $2.01 $2.03 $1.80 $1.92 139 400
Nov 02, 2016 $2.08 $2.13 $2.00 $2.03 28 400
Nov 01, 2016 $2.11 $2.12 $2.08 $2.08 18 600
Oct 31, 2016 $2.16 $2.20 $2.01 $2.10 132 300
Oct 28, 2016 $2.25 $2.25 $2.11 $2.18 118 400
Oct 27, 2016 $2.24 $2.30 $2.20 $2.23 46 900
Oct 26, 2016 $2.25 $2.31 $2.18 $2.25 38 500
Oct 25, 2016 $2.36 $2.36 $2.20 $2.25 244 800
Oct 24, 2016 $2.38 $2.39 $2.31 $2.33 64 500
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT